Altimmune to report third quarter 2022 financial results and provide business update on november 10

Gaithersburg, md., nov. 03, 2022 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2022 financial results on thursday, november 10, 2022 and will provide a business update.
ALT Ratings Summary
ALT Quant Ranking